SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-062108
Filing Date
2018-12-11
Accepted
2018-12-11 19:37:47
Documents
1
Period of Report
2018-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3691
  Complete submission text file 0001209191-18-062108.txt   5154
Mailing Address C/O ACORDA THERAPEUTICS, INC. 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address
FISHER MARY (Reporting) CIK: 0001272360 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 181229840

Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations